ߜ Aberrant autocrine control by peptide growth factors is a possible mechanism by which disordered regulation of cell proliferation may occur. The authors used the C6 glioma cell line as a model to study the role of basic fibroblast growth factor (bFGF) in tumor growth by transfection with bFGF complementary deoxyribonucleic acid in both the sense and antisense orientation. Clones with high messenger ribonucleic acid expression of the sense construct have increased proliferation in cell culture and increased levels of intracellular and extracellular bFGF. Clones with high expression of the antisense construct show decreased proliferation in culture and reduced levels of immunologically detectable bFGF. 
A S I C fi b ro blast growth factor (bFGF) is a potent a n gi ogenic factor and mitogen for a va riety of cells d e rived from mesoderm and neuro e c t o d e rm . 8 , 9 , 2 1 I t l a cks a signal peptide sequence and is not secreted by most cells in culture, although a pat h way indep e n d e n t of the endoplasmic re t i c u l u m -G o l gi complex has been d e s c ribed in fi b ro blasts tra n s fected with bFGF complem e n t a ry deox y ri b o nu cleic acid (cDNA ) .
1 5 Tra n s fection of m e l a n o cytes with bFGF cDNA has been shown to confe r autonomous growth in culture but is insufficient to produce tumori ge n e s i s ; 6 h oweve r, fi b ro blasts tra n s fected with a construct of bFGF fused to a signal peptide sequence t ra n s fo rm morp h o l ogi c a l ly, grow as nonadherent aggregates, and are highly tumori genic and metastat i c. Malignant glial tumors produce bFGF, 1 7 , 2 8 and its leve l of ex p ression ap p e a rs to corre l ate with the degree of m a l i g n a n cy and va s c u l a ri t y.
2 7 C o nve rs e ly, growth of tra n sfo rmed astro cytes in culture is suppressed by ex oge n o u s antisense bFGF oligo nu cl e o t i d e s .
3 , 1 6 , 1 8 A b e rrant reg u l at i o n of an autocrine pat h way involving bFGF is a possibl e m e chanism through wh i ch disord e red control of cell prol i fe ration may occur. To study the role of bFGF in glial tumor growth, the rat C6 astro cytoma cell line 2 , 4 has been used as a model both in vitro and in vivo. The C6 cells produce bFGF messenger ri b o nu cleic acid (mRNA) and seve ral bFGF protein species and, in addition, have higha ffinity FGF re c ep t o rs through wh i ch ex ogenous bFGF acts as a mitogen, confi rming its function as an autocri n e growth factor (our unpublished re s u l t s ) .
1 9 , 2 9 F u rt h e r, modu l ation of the level of functional growth factor through the a ddition of recombinant bFGF or specific neutra l i z i n g antibodies results in stimu l ation and inhibition, re s p e ct ive ly, of C6 xe n ografts grown in nude mice. 1 1 To further inve s t i gate the role of bFGF in malignant a s t ro cytoma growth, we tra n s fected C6 cells with a bov i n e bFGF cDNA 1 in both the sense and antisense ori e n t at i o n s . It was hy p o t h e s i zed that this would lead to increased and d e c reased ex p ression, re s p e c t ive ly, of bFGF and that this a l t e ration of the level of endogenous growth factor wo u l d result in altered tumor growth ch a ra c t e ri s t i c s .
Materials and Methods

Cell Culture
The C6 astrocytoma cells* were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), 10 g/ml streptomycin, and 10 U/ml penicillin in a humidified atmosphere containing 5% CO 2 and 95% air at 37˚C and subcultured every 3 to 5 days. A Coulter counter † was used to count cells for plating at specific concentrations and to determine cell numbers in proliferation assays.
Transfection of C6 Cells With bFGF cDNA
The C6 cells were transfected with bovine bFGF cDNA 1 in both the sense and antisense orientations. The plasmid used for the expression of bFGF was derived from pLTR, a simian virus 40 (SV40)-based vector (Fig. 1) , which includes the enhancer portion of the Harvey sarcoma virus long-terminal repeat and a dominant selectable marker, the Escherichia coli xanthine-guanine phosphoribosyltransferase (g p t) gene.
3 0 The 1.4-kb bovine bFGF cDNA, including the entire open reading frame for the mature protein (155 amino acids) as well as 103 nucleotides of 5Ј noncoding sequence and 832 nucleotides from the 3Ј untranslated region, was cloned into the E c oRI site of pLTR to yield the antisense plasmid pLTRbFGF(AS) and the sense plasmid pLTR-bFGF(S). Orientation of the cDNA insert was deduced from electrophoretic and Southern blot analyses of restriction enzyme fragments. Transfection using the sense and antisense orientation plasmids as well as vector alone was performed using lipofection, as described by Felgner, et al. 7 The C6 cells were plated at a density of 4 ϫ 1 0 5 cells per 60-mm dish. The following day, 20 g of plasmid DNA was dissolved in 50 l sterile water, mixed with 50 l Lipofectin ‡ in a polystyrene tube, mixed again, and allowed to stand at room temperature for 15 minutes. The cells were washed with phosphate-buffered saline (PBS), covered with 3 ml DMEM without FCS, and 100 l of DNA-Lipofectin solution added dropwise. Twelve hours later the medium was replaced with DMEM containing 10% FCS, and 36 hours later the cells were trypsinized and plated in the same medium at dilutions from 1:6 to 1:48.
Selection for g p t expression was initiated 48 hours after transfection by growing the cells in DMEM containing 10% FCS with hypoxanthine (15 g/ml), aminopterin (2 g/ml), thymidine (10 g / m l ) , mycophenolic acid (25 g/ml), and xanthine (250 g/ml). Stable transfectants were selected with cloning cylinders after 10 to 15 days and weaned from selection medium.
Northern Blot Analysis
Total cellular RNA was extracted from confluent cultures using the method of Sambrook, et al.
2 4 Aliquots of 10 g of RNA were dissolved in 50% formamide containing 20 mmol 3-n-morpholinopropanesulfonic acid and denatured with 3.7% formaldehyde at 55˚C for 15 minutes. The reaction was stopped on ice and 1-l loading buffer was added (0.4% bromphenol blue, 1 mmol ethylenediaminetetraacetic acid (EDTA), 50% glycerol). Samples were separated by electrophoresis on 1% agarose-formaldehyde gels at 50 V for 3 hours, capillary-transferred to a nitrocellulose filter overnight, and baked in a vacuum oven at 80˚C for 3 hours.
Baked nitrocellulose filters were prehybridized at 42˚C for 3 hours in a solution containing 50% formamide, 5 ϫ D e n h a r d t ' s solution (1 g Ficoll, 1 g polyvinylpyrrolidone, 1 g bovine serum albumin and water to 500 ml), 5 ϫ PIPES (750 mmol sodium chloride, 25 mmol 1,4-piperazinediethylene sulphonic acid, 25 mmol EDTA, pH 6.8), 0.2% sodium dodecyl sulphate (SDS), and 100 g/ml herring sperm DNA. For each probe, approximately 25 ng of the 1.4-kb bovine bFGF cDNA 1 was labeled with 3 2 P -d e o x y c y t i d i n e triphosphate by random primer labeling 2 4 to an activity of approximately 3 ϫ 10 5 cpm. Labeled probes were boiled for 5 minutes, chilled on ice for 5 minutes, and incubated overnight with the nitrocellulose filters at 42˚C. The filters were then washed at the same temperature in 2 ϫ standard saline citrate (SSC: 3 mol sodium chloride, 0.3 mol sodium citrate), 0.2% SDS for 30 minutes; 0.5 ϫ S S C , 0.2% SDS for 30 minutes; and 0.15 ϫ SSC, 0.2% SDS for 30 minutes. Hybridized filters were then exposed to Kodak XAR film at Ϫ70˚C for 24 hours.
Western Blot Analysis
Confluent cultures of C6 cells in 100-mm culture plates were lysed with 900 l of sample buffer containing 2% SDS, 0.0625 mol Tris-HCl (pH 6.8), 10% glycerol, 5% 2-mercaptoethanol, and 0.05% bromphenol blue. 1 3 The lysates were then sheared through a 21-gauge needle and stored at Ϫ20˚C. Samples for immunoblotting were electrophoresed on SDS-polyacrylamide gels containing 4% acrylamide in the stacking gel 12% acrylamide in the separating gel.
After gel electrophoresis, samples were electrophoretically transferred to nitrocellulose filters, blocked in 5% nonfat dry milk (NFDM) in PBS for 1 hour at room temperature, and then incubated overnight at 4˚C with monoclonal anti-bFGF antibody § diluted 1:100 in PBS. After washing in the PBS, the filters were incubated with biotinylated goat anti-mouse antibody diluted 1:250 in PBS-NFDM at room temperature for 1 hour followed by several washes in PBS, and incubated with Avidin DH and biotinylated alkaline phosphatase reagent for 1 hour. Antigen-antibody complexes were then detected by staining with 3.3 mg nitroblue tetrazolium and 1.65 mg 5-bromo-4-chloro-3-indolylphosphate in 10 ml alkaline phosphatase buffer (100 mmol Tris, 100 mmol NaCl, 5 mmol MgCl 2 , pH 9.5).
Immunocytochemical Assay
The C6 astrocytoma cells were grown to confluence on glass coverslips and fixed in 95% ethanol/5% glacial acetic acid (vol/vol) for 30 minutes at Ϫ20˚C, rinsed with PBS, and blocked with 10% normal goat serum in PBS for 30 minutes. After washing with PBS, the fixed cells were incubated for 1 hour with mouse monoclonal anti-FI G. 1. Diagram depicting pLTR, the transfection vector used in this study, containing the 1.4-kb bovine basic fibroblast growth factor (bFGF) complementary deoxyribonucleic acid cloned into the E c oRI site. The plasmid also contains the Harvey sarcoma virus 3Ј long terminal repeat (LTR), the simian virus-40 (SV40) 3Ј polyadenylation signal and origin of replication (SV40 ori), and the Escherichia coli guanine phosphoribosyltransferase gene. Amp r = ampicillin resistance. ‡ Lipofectin reagent supplied by Bethesda Research Laboratories, Bethesda, Maryland.
__________ § Monoclonal anti-bFGF antibody obtained from Upstate Biotechnology, Lake Placid, New York.
Avidin DH and biotinylated alkaline phosphatase reagent (Vectastain ABC kit) supplied by Vector Laboratories, Burlingame, C a l i f o r n i a .
bFGF antibody raised against a peptide corresponding to the deduced cDNA sequence of the extracellular domain of the chicken FGF type 1 receptor (FGFR-1, f l g) diluted 1:100. In control slides, the primary antibody was omitted. Coverslips were then washed with PBS and incubated for 1 hour with fluorescein isothiocyanate-conjugated goat anti-mouse or goat anti-rabbit immunoglobulin G, rinsed in PBS, and mounted on slides in PBS containing 50% (vol/vol) glycerol and 0.1% p-p h e n y l e n e d i a m i n e .
Growth Analysis of Transfected Cells
To assess the effects of over-or underexpression of bFGF in the presence and absence of media containing serum growth factors, transfectants and parent C6 cels were grown in DMEM with 10% FCS or in serum-free medium consisting of DMEM plus 50 g / m l insulin, 50 ng/ml transferrin, and 50 g/ml sodium selenite. Cells from log-phase cultures were seeded in 60-mm plates at the indicated densities in either DMEM plus 10% FCS or in serum-free medium. On Days 1 through 4 after plating, cells on triplicate plates were trypsinized and counted. Media were changed on remaining plates after 2 days. Testing for significant differences between sets of observations was conducted using Student's t-test for unpaired s a m p l e s .
Results
Expression of bFGF in Sense and Antisense Transfectants
Total RNA was ex t racted from cultures of parent C6 cells, controls tra n s fected with pLTR alone, sense tra n sfectants, and antisense tra n s fectants. Nort h e rn blot analysis using a labeled bovine bFGF cDNA probe was perfo rmed to determine the level of bFGF mRNA ex p re s s i o n . Pa rent C6 cells and control pLTR tra n s fectants ex p re s s e d a single 6.0-kb bFGF mRNA tra n s c ript at low leve l s . Antisense and sense tra n s fectants also ex p ressed the 6.0-kb band, but in addition had abundant ex p ression of bFGF m R NA tra n s c ripts of ap p rox i m at e ly 1.4 kb, 2.0 kb, and 2.5 kb corresponding to the tra n s fected cDNA of 1.4 kb alone as well as longer tra n s c ripts (Fi g. 2) .
The ex p ression of bFGF protein was studied in pare n t C6 cells and tra n s fectant clones by We s t e rn blot analy s i s of crude cell ly s ates. The amount of endogenous bFGF was too low to be detected in the parent C6 cells, the cont rol pLTR tra n s fectants, or the antisense tra n s fe c t a n t s . H oweve r, in each of the sense tra n s fectants there was an 18-kD band, indicating that the bFGF mRNA detected by Nort h e rn blot analysis was being tra n s l ated into the expected 155-amino acid protein product (Fi g. 3).
Immunocytochemical Localization of bFGF and FGFR-1
I m mu n o cy t o ch e m i s t ry using pri m a ry antibody aga i n s t bFGF demonstrated a reduction of cytoplasmic immu n ore a c t ivity in antisense tra n s fectants compared to pare n t C6 cells. The sense tra n s fectant clones had re m a rk ably i n c reased cytoplasmic immu n o re a c t iv i t y, indicating abu ndant intracellular bFGF. Th e re was also evidence of ex t racellular immu n o re a c t iv i t y, suggesting that the bFGF that was being ove rex p ressed in these clones was being secre ted into the ex t racellular mat rix. Th e re was no evidence of cell death or cy t o t ox i c i t y, wh i ch might explain the ex t racellular bFGF on the basis of leakage from dying cells. , antisense transfectant clones (AS-8, -9, and -10), and sense transfectant clones . Hybridization was performed with 3 2 P-labeled basic fibroblast growth factor (bFGF) complementary deoxyribonucleic acid (cDNA). The 6.0-kb band in each sample corresponds to the endogenous bFGF message. The antisense and sense clones express extremely high levels of messenger RNA corresponding to the bFGF cDNA insert. The positions of 28S RNA (large arrow) and 18S RNA (small arrow) are indicated. B: A shorter duration of exposure revealing distinct bands of approximately 1.4 kb, 2.0 kb, and 2.5 kb in the transfectant clones. Partial degradation of the endogenous and transfected bFGF message is apparent in clone A S -1 0 . C: The blot is stripped and hybridized with a labeled 18S RNA probe to demonstrate relative sample loading. FI G. 3. Western blot analysis of total protein extracted from C6 cells, plasmid-transfected controls, antisense and sense transfectants, incubated with anti-bovine basic fibroblast growth factor (bFGF) antibody. Coomassie blue staining of an identical gel (not shown) confirms relatively uniform sample loading. Lane 1 contains prestained, colored size markers. Samples are labeled as in Fig. 2 . An 18-kD band, corresponding to the bovine bFGF protein, is detected only in the sense clones.
The re l at ive abundance of FGFR-1 also ap p e a red to be a l t e red as a result of tra n s fection with bFGF. In antisense clones there was somewh at gre ater punctate immu n o re a ct ivity corresponding to the high-affinity re c eptor than t h at seen in the parent C6 cells; howeve r, there was a p ro found reduction in the immu n o re a c t ivity for re c ep t o rs detected in the sense clones that we re ove rex p re s s i n g bFGF (Fi g. 4).
In Vitro Growth Analysis of Transfected Cells
Two high-ex p ressing antisense tra n s fectant cl o n e s (AS-9 and AS-10) we re compared to parent C6 cells and c o n t rol pLTR tra n s fectants (clone pLTR-14) to determ i n e the effect of antisense bFGF mRNA on the rate of cell growth in culture (Fi g. 5A and B). On Day 0, 3.0 ϫ 1 0 5 cells we re seeded in 60-mm plates. Th e re was no diffe r-FI G. 4. Immunocytochemical analysis of basic fibroblast growth factor (bFGF) and FGF receptor in C6 cells and bFGF antisense and sense transfectants. Parental C6 cells show a moderate amount of cytoplasmic immunoreactivity for bFGF (A) and punctate FGF receptors predominantly localized to the cell membrane (B). Antisense transfectants (clone AS-10) have low levels of bFGF (C) but increased immunoreactivity for FGF receptors (D). Sense transfectants (clone FGF-37) demonstrate high levels of bFGF immunoreactivity both intracellularly and within the extracellular matrix (E), whereas FGF receptor immunoreactivity is reduced (F). Original magnification, ϫ 6 3 0 . ence in growth rate between the parent cell line and the p l a s m i d -t ra n s fected control line, and the pro l i fe ration of both antisense clones was re d u c e d. The diffe rences in cell number we re diminished by the 4th day in culture as the p a rent C6 cells and control tra n s fectants re a ched plat e a u p h a s e, while the antisense tra n s fectants continued to prol i fe rate at a slower rat e. Th e re fo re, statistical analysis wa s based on the number of cells per dish on the 3rd day. G rowth of the antisense clones compared to C6 cells wa s reduced by 24% to 32% in DMEM plus FCS (p Ͻ 0 . 0 0 5 ) and by 23% to 58% in seru m -f ree medium (p Ͻ 0 . 0 0 5 ) .
G rowth of two high-ex p ressing sense tra n s fe c t a n t
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Role of bFGF in tumor growth FI G. 5. Graphs illustrating growth of basic fibroblast growth factor (bFGF) antisense and sense transfectants. Cells from log-phase cultures were seeded in 60-mm plates at the indicated densities in either Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal calf serum (FCS) clones (FGF-24 and FGF-37) was compared to pare n t C6 cells to assess the effect of high levels of endoge n o u s bFGF on pro l i fe ration in vitro. On Day 0, 1.0 ϫ 1 0 5 c e l l s we re seeded in 60-mm plates. The sense tra n s fe c t a n t clones grew more rap i d ly and re a ched plateau phase after 3 days in culture (Fi g. 5C and D); there fo re, stat i s t i c a l c o m p a rison of cell number was based on cell counts on the 3rd day. Growth rate of the sense tra n s fectants wa s i n c reased re l at ive to the parent cell line by 29% to 88% in DMEM plus FCS (p Ͻ 0.005), and by 16% to 71% in s e ru m -f ree medium (p Ͻ 0.005). In medium containing F C S, the tra n s fectants also re a ched gre ater cell density at p l ateau phase because of a tendency to pile up in large h e aps, a fe at u re not seen in parent C6 cells. It is import a n t to note that although the sense clones grew faster than parent C6 cells for the fi rst 3 days in both culture conditions, by the 4th day the sense tra n s fectants in seru m -f ree medium had begun to die, while the parent C6 cells continu e d to grow. This suggests that the grow t h -p romoting effect of bFGF was dependent on nu t rients or other fa c t o rs in the medium that became depleted during the rapid phase of cell pro l i fe rat i o n .
Discussion
Aberrant Stimulation by Growth Factors
Peptide growth fa c t o rs are substances that play a major role in the control of cell growth, division, and diffe re n t iation. In contrast to typical hormones of the endocri n e system, wh i ch are secreted into the bl o o d s t ream and cause their effects at a distance, most growth fa c t o rs appear to act in a local fashion by diffusion from their sourc e. Pa ra c rine stimu l ation re fe rs to the effect of a secre t e d growth factor on adjacent or prox i m ate cells, wh e re a s a u t o c rine stimu l ation describes the situation in wh i ch cells p roduce a growth factor to wh i ch they also re s p o n d. A diso rder of grow t h -factor reg u l ation that may be of part i c u l a r s i g n i ficance is the ge n e ration of unre s t rained autocri n e s t i mu l ation, because a population of self-stimu l ating cells m ay have little, if any, fe e d b a ck control on its pers i s t e n t expansion. Such disord e red reg u l ation of cell pro l i fe rat i o n is one of seve ral possible molecular mechanisms that may result in the process of neoplastic tra n s fo rm at i o n .
Tumor evolution is a mu l t i s t ep process involving loss of c o n t rol of the interd ependent systems re s p o n s i ble for cellular pro l i fe ration and diffe re n t i at i o n . 1 4 Once neoplastic cells have become establ i s h e d, continued growth re q u i re s the development of sufficient vascular supply, a pro c e s s t e rmed angi oge n e s i s .
8 Studies have focused on bFGF as a possible angi ogenic factor and promoter of tumor grow t h . 6 , 8 , 1 2 , 2 2 Basic FGF is a member of a fa m i ly of at least seven re l ated poly p eptides that have similar biological activities including angi ogenesis, wound rep a i r, tissue rege n e ration, embryonic development and diffe re n t i at i o n , m o d u l ation of endocrine function, and neuro t ro p h i c e ffe c t s . 
Expression of bFGF in Cerebral Neoplasms
A high degree of stru c t u ral homology exists betwe e n bFGF and seve ral oncogenes including i n t-2 and h s t, suggesting a role for this factor in malignant tra n s fo rm at i o n .
6 , 3 1 E x p ression of bFGF has been demonstrated in a va riety of human cereb ral neoplasms including astrocytomas, ep e n dymomas, glioblastomas, meningi o m a s , n e u rilemomas, oligo d e n d rogliomas, and ch o roid plex u s p ap i l l o m a s . 1 2 , 1 7 , 2 8
To inve s t i gate the cellular role of bFGF, attempts have been made to alter the level of this growth fa c t o r, either by t ra n s fection with bFGF cDNA or through the addi-tion of ex ogenous bFGF or neutralizing antibody. Ove rex p ression of bFGF by tra n s fection has resulted in t ra n s fo rm ation of a number of cell types including mel a n o cy t e s 6 and fi b ro bl a s t s .
2 2 E x ogenous bFGF stimu l at e s p ro l i fe ration in human glioma cells, 1 7 although its effe c t on pro l i fe ration of rat C6 astro cytoma cells has been prev i o u s ly rep o rted as both positive 1 9 and negat ive, 2 9 the diffe rences possibly arising from va ri ation in culture and ex p e rimental conditions. Anti-bFGF antibody reduces the p ro l i fe ration of glioma cells in vivo, 1 1 and reduction of bFGF ex p ression through the use of antisense oligo nucleotides has been shown to inhibit the growth of human a s t ro cytoma cell lines.
1 6 , 1 8 S t able tra n s fection of astro cytoma cells with bFGF DNA, as demonstrated in this study, has not been prev i o u s ly rep o rt e d.
The C6 cell line 2 , 4 is a we l l -ch a ra c t e ri zed glioma model t h at has been ex t e n s ive ly studied and has the histologi c a l ch a ra c t e ristics of a malignant glial neoplasm incl u d i n g nu clear pleomorphism, vascular endothelial pro l i fe rat i o n , and necro s i s .
2 3 In this study, tra n s fection with sense and antisense bFGF cDNA was used to produce clones with i n c reased and decreased levels of endogenous bFGF ex p ression to elucidate the role of bFGF in malignant a s t ro cytoma growth. It is like ly that significant improvement in the results of tre atment for malignant glial neoplasms will depend on a gre ater understanding of these fundamental molecular mechanisms, wh i ch may be res p o n s i ble for tumor development, and the evolution of t h e rapeutic strat egies employing va rious molecular methods targeted at these specific cellular pro c e s s e s .
The ex p ression of basic FGF in C6 astro cytoma cells d e s c ribed in this study is consistent with previous rep o rt s t h at have demonstrated the presence of bFGF in this 1 9 , 2 9 and other 1 7 , 2 8 malignant astro cytoma cell lines and tumors . N o rt h e rn blot analysis has revealed the presence of a single 6.0-kb bFGF mRNA tra n s c ript, wh i ch is identical to t h at rep o rted in adult rat hy p o t h a l a mus and cort ex by Shimasaki, et al.
2 6 The demonstration of bFGF within C6 a s t ro cytoma cells is significant because bFGF has been a s s o c i ated with ab n o rmal growth reg u l ation in a nu m b e r of human neuro e c t o d e rmal tumors .
1 0 F u rt h e rm o re, elevated levels of bFGF, fo l l owing tra n s fection of melanocy t e s with va rious cDNA ex p ression ve c t o rs, promote nu m e rous phenotypic ch a n ges including ch a n ges in morp h o l ogy and anch o rage -i n d ependent grow t h . 6 To further emphasize the importance of bFGF to cell growth, the addition of antisense bFGF oligo nu cleotides leading to reduced bFGF ex p ression has resulted in reduced astro cytoma growth i n v i t ro. benign than malignant gliomas. Howeve r, malignant gliomas have re c e n t ly been shown to ex p ress gre at e r quantities of bFGF mRNA re l at ive to meningiomas, and the level of bFGF mRNA ex p ression in human gliomas ap p e a rs to corre l ate with fe at u res of malignancy.
2 7 Th e acquisition of an unreg u l ated autocrine loop invo l v i n g bFGF is pro b ably one step along a mu l t i s t ep pat h way of mu t ations or cellular alterations leading to neoplasia.
Expression of bFGF in Transfected C6 Cells
The effect of high ex p ression of antisense bFGF mRNA on C6 cell growth attests to the effi c a cy of this tech n i q u e and the importance of bFGF in glioma growth. Under the c o n t rol of the stro n g, constitutive promoter in pLTR, antisense mRNA was ge n e rated in abu n d a n c e. The antisense t ra n s c ripts of 2.0 kb and 2.5 kb corresponded to the 1.4-kb bFGF cDNA together with splice and SV40 polya d e ny l ation regions from pLTR. A third tra n s c ript of 1.4 kb most l i ke ly rep resents the bFGF cDNA insert without a poly ( A ) tail. All three tra n s c ripts are of ap p rox i m at e ly the same s i ze as those found to be most effe c t ive in studies ex a m i ning optimization of antisense va ri abl e s .
5
The reduction of bFGF ex p ression at the protein level, as demonstrated by immu n o cy t o ch e m i s t ry, was not prim a ri ly a result of degra d ation of endogenous bFGF m R NA. Nort h e rn blot analysis cl e a rly demonstrated the p resence of the nat ive 6.0-kb tra n s c ript, even in cl o n e s with ex t re m e ly high levels of antisense message. Howeve r, it is interesting to note that the one clone that did appear to have at least partial absence or degra d ation of the endogenous message (AS-10) had the gre atest re d u ction in growth rat e. The fact that some degra d ation wa s seen may indicate that in this clone some of the antisense e ffect resulted from inhibition at the level of RNA tra n sc ription, mRNA splicing, or tra n s p o rt, wh e reas in the other clones, this effect must have resulted from interfe rence with tra n s l ation of the endogenous mRNA into functional protein. A definite re l ationship between amount of antisense tra n s c ript and degree of growth inhibition wa s not ap p a re n t .
Effect of Transfection With bFGF cDNA on Cell Growth
Th e re was significant inhibition of cell growth in the antisense tra n s fectant clones. It is important to note that this inhibition was not present in control cells tra n s fe c t e d with the vector alone. Th e re was no diffe rence betwe e n clone pLTR-14 and the parent C6 cells in terms of endogenous mRNA ex p ression, bFGF immu n o re a c t iv i t y, and growth rat e. Thus, the process of tra n s fection with the p LTR vector alone was not inhere n t ly toxic and it did not p rovide a growth adva n t age to tra n s fectant cl o n e s .
The fact that antisense inhibition of growth was seen in c u l t u re conditions with and without serum growth fa c t o rs a rgues stro n g ly for the importance of endogenous bFGF in C6 growth, that is, an autocrine mechanism. It might be expected that in culture medium containing serum any e ffect caused by reducing the ex p ression of bFGF wo u l d be ove rcome by abundant serum growth fa c t o rs, but this was not the case. The results support the possibility of an i n t e raction between intracellular bFGF and its re c ep t o r t h at cannot be duplicated by ex ogenous growth fa c t o r.
Because the antisense clones continued to grow,
